confer
stem
cell
cell
therapi
lung
biolog
lung
diseas
held
juli
univers
vermont
review
current
understand
role
stem
progenitor
cell
lung
repair
injuri
review
current
statu
cell
therapi
ex
vivo
bioengin
approach
lung
diseas
rapidli
expand
area
studi
provid
insight
challeng
tradit
view
mechan
lung
repair
injuri
pathogenesi
sever
lung
diseas
goal
confer
summar
current
state
field
discuss
debat
current
controversi
identifi
futur
research
direct
opportun
basic
translat
research
cellbas
therapi
lung
diseas
goal
articl
accompani
formal
confer
report
provid
comprehens
review
publish
literatur
lung
regen
medicin
last
confer
report
decemb
companion
articl
confer
report
stem
cell
cell
therapi
lung
biolog
diseas
held
univers
vermont
juli
comprehens
summari
relev
publish
literatur
rapidli
grow
field
stem
cell
cell
therapi
bioengin
lung
biolog
diseas
present
review
discuss
develop
area
specif
focu
advanc
publish
literatur
comprehens
review
previou
literatur
field
summar
report
previou
workshop
reader
also
refer
number
recent
review
publish
past
approxim
year
publish
posit
american
thorac
societi
embryon
stem
cell
research
stem
cell
medic
tourism
addit
recent
review
publish
past
approxim
year
specif
topic
discuss
includ
section
accord
recent
guidelin
american
thorac
societi
respiratori
diseas
organ
term
clara
cell
clara
cell
secretori
protein
replac
term
club
cell
club
cell
secretori
protein
ccsp
respect
suggest
nomenclatur
overal
confer
recommend
shown
tabl
respect
number
public
past
approxim
year
explor
question
whether
bone
marrow
bm
deriv
cell
includ
hematopoiet
stem
cell
mesenchym
stromal
stem
cell
msc
endotheli
progenitor
cell
epc
popul
well
stem
progenitor
cell
isol
tissu
adipos
placenta
cord
blood
other
could
structur
engraft
matur
differenti
airway
alveolar
epitheli
cell
pulmonari
vascular
interstiti
cell
literatur
extens
discuss
review
previou
confer
elsewher
current
consensu
lung
epitheli
engraft
rare
phenomenon
unlik
physiolog
signific
review
continu
interest
structur
engraft
recent
literatur
continu
examin
whether
cell
popul
lineagedeplet
nonhematopoiet
bm
cell
unfraction
bm
cord
bloodderiv
hematopoiet
progenitor
cell
amniot
fluidderiv
cell
discuss
could
engraft
effect
recent
report
describ
popul
ccsp
express
adult
marrow
cell
mice
appear
robustli
lodg
engraft
lung
system
intratrach
administr
compar
popul
cell
isol
pig
bm
express
embryon
stem
cell
marker
stagespecif
embryon
antigen
well
ccsp
cytokeratin
occludin
grown
commerci
avail
epitheli
differenti
growth
medium
cell
express
aquaporin
surfact
protein
c
spc
target
infect
influenza
viru
recent
studi
tend
use
sophist
microscop
analyt
techniqu
earlier
studi
nonetheless
epitheli
engraft
gener
continu
rare
remain
unclear
physiolog
signific
parallel
studi
suggest
rare
appar
engraft
pulmonari
interstitium
vasculatur
total
marrow
transplant
varieti
injuri
model
review
despit
continu
interest
possibl
engraft
exogen
cell
lung
emphasi
remain
area
notabl
immumomodulatori
effect
administ
cell
ex
vivo
tissu
engin
endogen
tissu
stem
cell
thought
contribut
tissu
mainten
repair
best
character
intestin
skin
cell
rare
undifferenti
local
special
nich
within
tissu
lung
endogen
epitheli
stem
progenitor
cell
thought
contribut
epitheli
mainten
injuri
repair
larg
literatur
mous
model
grow
literatur
describ
put
endogen
distal
airway
stem
progenitor
cell
human
lung
review
refer
recent
review
publish
studi
gener
controversi
uniform
agreement
ident
andor
function
endogen
lung
epitheli
stem
progenitor
cell
mous
human
lung
smaller
grow
literatur
also
describ
endogen
stem
progenitor
cell
function
replac
damag
stroma
pulmonari
vasculatur
predominantli
mous
model
howev
one
persist
issu
literatur
terminolog
nomenclatur
use
term
stem
progenitor
often
use
interchang
inconsist
endogen
adult
tissuespecif
stem
cell
best
appreci
cell
capac
selfrenew
give
rise
daughter
cell
term
transit
amplifi
cell
give
rise
special
differenti
cell
specif
organ
gener
tissuespecif
stem
cell
wide
potenti
differenti
capac
contrast
adult
endogen
progenitor
cell
best
appreci
tissuespecif
cell
selfrenew
differenti
special
cell
propos
differenti
cell
type
induc
mitot
activ
state
capac
cell
term
facult
progenitor
cell
facult
progenitor
cell
perform
gener
tissu
function
daili
basi
enter
mitot
cell
pool
tissu
injuri
repair
thu
facult
progenitor
cell
pool
function
larg
broadli
distribut
pool
repar
cell
supplement
repar
capac
tissu
stem
cell
altern
facult
progenitor
pool
may
serv
routin
tissu
homeostasi
regener
wherea
tissu
stem
cell
come
play
extrem
situat
injuri
propos
list
terminolog
includ
report
confer
repeat
tabl
although
degre
consensu
propos
definit
disagr
ongo
debat
discuss
nonetheless
analys
lung
stem
progenitor
cell
anim
model
particularli
mous
provid
import
advanc
past
year
remain
unclear
whether
paradigm
hierarchi
describ
endogen
stem
progenitor
cell
organ
intestin
skin
also
appli
lung
particularli
lung
epithelium
lung
complex
organ
contain
mani
distinct
epitheli
cell
type
distribut
sever
differ
region
microenviron
along
pulmonari
tract
depict
schemat
form
figur
consequ
although
identif
cell
prolifer
steadyst
injuri
condit
rel
straightforward
character
classif
mitot
activ
put
endogen
stem
progenitor
epitheli
cell
hierarchi
challeng
remain
question
whether
cell
arrang
hierarchi
hierarchi
cell
arrang
defin
characterist
cell
differ
level
hierarchi
differenti
prolifer
potenti
intestin
advanc
lineagetrac
model
techniqu
mice
begun
provid
addit
inform
howev
lineagetrac
approach
need
avail
method
compar
assess
lineag
hierarchi
put
human
lung
epitheli
stem
progenitor
cell
consider
specif
lung
includ
cell
cycl
time
frequenc
adult
lung
tissu
low
constitut
epitheli
turnov
rate
lung
injuri
model
use
mice
anim
model
identifi
stem
cell
progenitor
cell
induc
cellular
prolifer
repopul
lung
epithelium
injuri
model
specif
particular
region
lung
epithelium
exampl
sulfur
dioxid
ozon
nitrogen
dioxid
inhal
damag
tracheal
larg
airway
epithelium
use
studi
proxim
airway
stem
cell
progenitor
cell
review
naphthalen
administr
specif
injur
club
cell
bronchiolar
epithelium
bleomycin
administr
injur
alveolar
epithelium
use
studi
distal
airway
alveolar
region
model
provid
strong
evid
region
specif
lung
epitheli
stem
progenitor
popul
mous
lung
exampl
mous
least
five
popul
airway
epitheli
cell
identifi
abil
enter
cell
cycl
injuri
lung
thu
consid
facult
progenitor
cell
basal
clublik
club
pulmonari
neuroendocrin
type
atii
alveolar
epitheli
cell
differ
club
cell
clublik
cell
highlight
difficulti
identifi
facult
progenitor
clublik
cell
cell
express
ccsp
tabl
glossari
definit
terminolog
potenc
sum
development
option
avail
cell
totipot
abil
singl
cell
divid
produc
differenti
cell
organ
includ
extraembryon
tissu
thu
gener
organ
total
mammal
zygot
first
cleavag
blastomer
totipot
pluripot
abil
singl
cell
produc
differenti
cell
type
repres
three
embryon
germ
layer
thu
form
lineag
matur
organ
exampl
embryon
stem
cell
multipot
abil
adult
stem
cell
form
multipl
cell
type
one
lineag
exampl
hematopoiet
stem
cell
unipot
cell
form
one
cell
type
exampl
spermatogoni
stem
cell
gener
sperm
reprogram
chang
epigenet
lead
increas
potenc
dedifferenti
induc
nuclear
transfer
cell
fusion
genet
manipul
transdifferenti
capac
differenti
somat
cell
acquir
phenotyp
differenti
cell
differ
lineag
exampl
epithelialmesenchym
transit
process
wherebi
fulli
differenti
epitheli
cell
undergo
transit
mesenchym
phenotyp
give
rise
fibroblast
myofibroblast
plastic
hypothesi
somat
stem
cell
broaden
potenc
gener
cell
lineag
concept
controversi
mammal
embryon
stem
cell
esc
cell
line
develop
inner
cell
mass
earli
develop
blastocyst
esc
capac
selfrenew
pluripot
abil
differenti
cell
embryolog
lineag
adult
cell
type
howev
esc
form
extraembryon
tissu
trophectoderm
adult
stem
cell
cell
isol
adult
tissu
includ
bone
marrow
adipos
tissu
nervou
tissu
skin
umbil
cord
blood
placenta
capac
selfrenew
gener
adult
stem
cell
multipot
capac
differenti
matur
cell
type
parent
tissu
popul
adult
stem
cell
msc
exhibit
rang
lineag
differenti
limit
singl
tissu
type
whether
adult
stem
cell
exhibit
plastic
differenti
wider
varieti
differenti
cell
tissu
remain
controversi
adult
tissuespecif
stem
cell
adult
stem
cell
defin
tissu
specif
rel
undifferenti
cell
within
given
tissu
capac
selfrenew
stabl
mainten
within
stem
cell
nich
adult
tissuespecif
endogen
stem
cell
differenti
potenti
equival
cellular
divers
tissu
resid
hematopoiet
stem
cell
prototyp
adult
tissu
stem
cell
induc
pluripot
stem
cell
ipsc
reprogram
adult
somat
cell
undergon
dedifferenti
express
reprogrammingtranscript
factor
oct
cmyc
ipsc
similar
esc
morpholog
prolifer
gene
express
abil
form
teratoma
vivo
implant
ipsc
result
format
tissu
three
embryon
germ
layer
ipsc
gener
mous
human
cell
progenitor
cell
collect
term
use
describ
prolif
cell
capac
differenti
differ
cell
lineag
within
given
tissu
unlik
stem
cell
progenitor
cell
limit
selfrenew
capac
term
progenitor
cell
commonli
use
indic
cell
expand
rapidli
undergo
senesc
multipl
cell
doubl
terminolog
take
account
function
distinct
among
progenitor
cell
suggest
transitamplifi
cell
progeni
endogen
tissu
stem
cell
retain
rel
undifferenti
charact
although
differenti
parent
stem
cell
finit
capac
prolifer
sole
function
transitamplifi
cell
gener
suffici
number
special
progeni
tissu
mainten
oblig
progenitor
cell
cell
lose
abil
prolifer
commit
differenti
pathway
intestin
transitamplifi
cell
oblig
progenitor
cell
facult
progenitor
cell
cell
exhibit
differenti
featur
quiescent
state
yet
capac
prolifer
normal
tissu
mainten
respons
injuri
bronchiolar
club
cell
exampl
cell
type
classic
stem
cell
hierarchi
stem
cell
hierarchi
adult
tissu
stem
cell
activ
particip
normal
tissu
mainten
give
rise
transitamplifi
cell
within
type
hierarchi
renew
potenti
resid
cell
top
hierarchi
ie
stem
transitamplifi
cell
cell
success
stage
prolifer
becom
progress
differenti
nonclass
stem
cell
hierarchi
stem
cell
hierarchi
adult
tissu
stem
cell
typic
particip
normal
tissu
mainten
activ
particip
repair
progenitor
cell
deplet
rapidli
renew
tissu
tissu
homeostasi
depend
mainten
activ
mitot
compart
rapid
turnov
differenti
cell
type
requir
continu
prolifer
stem
andor
transitamplifi
cell
prototyp
rapidli
renew
tissu
intestin
epithelium
slowli
renew
tissu
tissu
steadyst
mitot
index
low
special
cell
type
broadli
distribut
longliv
subset
cell
facult
progenitor
cell
retain
abil
enter
cell
cycl
rel
stabil
differenti
cell
pool
parallel
infrequ
prolifer
stem
andor
transit
amplifi
cell
lung
exampl
slowli
renew
tissu
hematopoiet
stem
cell
cell
capac
selfrenew
whose
progeni
differenti
differ
blood
cell
lineag
includ
matur
leukocyt
erythrocyt
platelet
endotheli
progenitor
cell
circul
cell
potenti
prolifer
differenti
matur
endotheli
cell
studi
trachea
larg
airway
compart
contain
two
major
epitheli
cell
lineag
basal
secretorycili
cell
basal
cell
express
high
level
transcript
factor
cytokeratin
aquaporin
isol
fluorescenceactiv
cell
sort
use
express
nerv
growth
factor
receptor
lineag
trace
studi
mous
reveal
basal
cell
give
rise
club
ciliat
cell
proxim
airway
homeostasi
sulfur
dioxid
injuri
mice
cell
signal
pathway
includ
bcatenin
notch
tissu
factor
appear
regul
function
fate
basal
epitheli
cell
recent
data
suggest
mice
facult
progenitor
cell
pool
account
much
airway
epitheli
cell
replac
normal
homeostasi
also
significantli
contribut
tissu
repair
cellular
injuri
contrast
older
pulsechas
studi
demonstr
fibrocyt
cell
subset
circul
leukocyt
produc
collagen
home
site
inflamm
ident
phenotyp
character
circul
fibrocyt
firmli
establish
epc
cell
express
cell
surfac
marker
mhc
ii
also
express
type
collagen
fibronectin
bronchiolar
stem
cell
term
appli
rare
popul
toxin
ie
naphthalen
resist
club
cell
secretori
protein
ccsp
express
cell
local
neuroepitheli
bodi
bronchoalveolar
duct
junction
rodent
lung
cell
prolifer
infrequ
steadyst
increas
prolif
rate
deplet
transitamplifi
club
cell
lineag
trace
studi
indic
cell
differenti
potenti
replenish
special
cell
type
bronchiolar
epithelium
human
correl
identifi
bronchioalveolar
stem
cell
term
appli
small
popul
cell
locat
bronchoalveolar
duct
junction
mice
identifi
vivo
dual
label
ccsp
surfact
protein
c
spc
resist
destruct
toxin
ie
naphthalen
cultur
duallabel
cell
also
express
selfrenew
give
rise
progeni
express
ccsp
prospc
aquaporin
lead
specul
singl
cell
type
capac
differenti
bronchiolar
club
cell
alveolar
type
pneumocyt
lineag
relationship
cell
studi
vitro
observ
dual
label
vivo
unclear
human
correl
identifi
adapt
permiss
refer
clublik
cell
serv
selfrenew
cell
type
progenitor
ciliat
airway
cell
rat
howev
recent
lineag
trace
clublik
cell
demonstr
clublik
cell
replenish
cell
type
tracheal
proxim
airway
lack
consensu
whether
stem
cell
particip
repair
upper
airway
epithelium
reflect
need
use
comprehens
rang
analyt
method
individu
studi
remain
vermont
stem
cell
confer
signific
limit
field
howev
despit
use
multipl
injuri
model
vivo
includ
exposur
deterg
naphthalen
well
vitro
analys
suggest
subset
basal
cell
serv
role
tissu
stem
cell
facult
progenitor
cell
upper
airway
mice
similar
conclus
deriv
use
human
proxim
airway
basal
epitheli
cell
ex
vivo
vitro
cultur
system
overal
data
trachea
larger
airway
although
limit
provid
strongest
evid
date
lung
tissuespecif
stem
cell
howev
situat
complex
may
subpopul
basal
epitheli
cell
restrict
lineag
specif
role
exampl
popul
bright
aldh
cell
act
progenitor
cell
repair
naphthaleneinjur
tracheal
epithelium
recent
stemprogenitor
popul
tracheal
submucos
gland
duct
cell
identifi
appear
capabl
regener
submucos
gland
tubul
duct
surfac
epithelium
hypoxicischem
injuri
mice
predomin
epitheli
cell
smaller
airway
noncili
club
cell
exhibit
characterist
facult
progenitor
cell
injuri
ciliat
airway
epitheli
cell
howev
unlik
transitamplifi
cell
tissu
higher
rate
epitheli
turnov
intestin
club
cell
exhibit
low
prolif
index
steadyst
broadli
distribut
throughout
bronchiolar
epithelium
contribut
special
tissu
function
earlier
pulsechas
studi
identifi
club
cell
progenitor
ciliat
cell
sophist
lineag
trace
method
subsequ
studi
demonstr
mous
lung
club
cell
selfrenew
function
progenitor
distal
airway
ciliat
cell
homeostasi
howev
avail
data
suggest
fundament
differ
clublik
club
secretori
cell
proxim
versu
distal
airway
respect
thu
situat
remain
complic
anoth
wide
use
approach
club
cellspecif
toxin
naphthalen
use
extens
deplet
bronchiolar
club
cell
pool
mous
model
popul
naphthaleneresist
cell
term
variant
club
cell
vce
identifi
older
studi
bronchiolar
stem
cell
vce
locat
within
discret
microenviron
includ
two
differ
stemprogenitor
cell
nich
neuroepitheli
bodi
bronchoalveolar
duct
junction
anoth
naphthaleneresist
progenitor
cell
popul
locat
bronchoalveolar
duct
junction
identifi
base
coexpress
ccsp
atii
cell
marker
spc
term
bronchoalveolar
stem
cell
basc
basc
isol
use
fluorescenceactiv
cell
sort
select
cell
express
stem
cell
marker
elimin
hematopoiet
cell
endotheli
cell
neg
neg
po
recent
studi
shown
neg
neg
po
popul
heterogen
previous
appreci
robust
marker
profil
enrich
basc
use
neg
neg
epcam
po
low
low
flow
cytometr
separ
sever
overlap
stemprogenitor
cell
popul
recent
isol
mous
lung
base
flow
cytometr
isol
cell
exhibit
neg
neg
epcam
hi
po
po
low
neg
neg
neg
epcam
po
low
autofluoresc
lowpopul
phenotyp
cell
form
coloni
express
airway
andor
alveolar
lineag
marker
threedimension
cocultur
matrigel
assay
primari
lung
mesenchym
cell
latter
phenotyp
contain
naphthaleneresist
bronchiolar
progenitor
contrast
neg
neg
neg
epcam
po
low
autofluoresc
highpopul
cell
contain
naphthalenesensit
club
cell
recent
describ
popul
put
mous
lung
distal
airway
progenitor
cell
popul
includ
popul
integrin
po
spc
neg
cell
po
po
cell
po
po
cell
cell
differ
local
airway
tree
may
function
differ
repair
experiment
induc
lung
injuri
critic
point
studi
highlight
care
meticul
use
isol
character
techniqu
includ
flow
cytometri
immunohistochemistri
must
use
conceiv
sever
abovement
distal
airway
epitheli
progenitor
popul
repres
cell
phenotyp
variant
cell
popul
character
differ
way
differ
laboratori
divers
interpret
highlight
wide
recogn
need
marker
specif
function
distinct
cell
popul
precis
tool
lineag
trace
underscor
import
vivo
microenviron
nich
cell
behavior
increas
collabor
cross
fertil
share
compar
method
essenti
howev
phenotyp
character
enough
function
assay
includ
lineag
trace
differenti
capac
critic
assess
robust
vitro
assay
recapitul
vivo
environ
eg
repopul
decellular
lung
scaffold
add
insight
vivo
assay
eg
cell
transplant
need
assess
abil
put
lung
stemprogenitor
cell
reconstitut
lung
epitheli
cell
lineag
within
damag
diseas
tissu
complic
put
airway
progenitor
cell
may
quiescent
respons
injuri
eg
ozon
deplet
ciliat
cell
pool
fact
bronchiolar
stem
cell
play
greater
role
normal
airway
epitheli
homeostasi
turnov
abund
pool
facult
progenitor
club
cell
studi
suggest
neuroepitheli
bodyassoci
vce
like
function
reserv
popul
function
normal
mainten
relevantli
deplet
facult
progenitor
pool
vce
addit
studi
need
confirm
clarifi
hypothesi
mous
human
lung
thu
although
progress
made
clarifi
ident
role
distal
airway
progenitor
cell
mice
role
cell
popul
normal
homeostasi
respons
sever
injuri
remain
unclear
bronchiolar
progenitor
basc
number
enhanc
lung
tumorigenesi
review
cell
signal
pathway
wnt
bcatenin
hedgehog
notch
cell
implic
stem
cell
function
lung
tissu
howev
although
stimul
wntbcatenin
cell
signal
appear
promot
airway
submucos
gland
develop
inhibit
differenti
bronchiolar
stem
cell
lung
appear
play
key
role
mainten
repair
bronchiolar
epithelium
precis
role
pathway
endogen
lung
stem
progenitor
cell
remain
determin
ident
potenti
endogen
airway
progenitor
cell
human
lung
remain
less
well
understood
signific
differ
structur
cellular
composit
mous
human
lung
exampl
submucos
gland
pseudostratifi
epithelium
contain
basal
cell
region
restrict
trachea
upper
airway
mice
extend
trachea
distal
airway
human
addit
vce
basc
identifi
human
lung
tissu
therefor
intens
investig
compar
contrast
put
endogen
airway
stem
progenitor
popul
mous
human
lung
sore
need
sever
laboratori
recent
describ
put
proxim
distal
airway
epitheli
progenitor
cell
isol
human
lung
includ
ckit
po
cell
appear
gener
endoderm
mesoderm
lineag
tissu
cultur
inject
mous
lung
cryoinjuri
cell
popul
appear
capabl
stimul
particip
repair
airway
pulmonari
vasculatur
pulmonari
interstitium
true
model
would
overturn
current
concept
singl
multipot
lung
stem
progenitor
cell
capabl
gener
smooth
muscl
vasculatur
airway
alveoli
find
gener
intens
discuss
requir
function
character
valid
laboratori
although
attract
specul
lung
diseas
may
part
consequ
endogen
lung
stem
progenitor
cell
failur
studi
need
draw
direct
connect
particular
littl
known
progenitor
cell
function
chronic
diseas
emphysema
idiopath
pulmonari
fibrosi
suggest
inform
avail
genet
lung
diseas
cystic
fibrosi
cf
airway
epithelium
patient
cf
contain
cuboid
cell
express
primit
cell
marker
includ
thyroid
transcript
factor
cytokeratin
review
neuroepitheli
cell
also
express
cf
transmembran
conduct
regul
protein
cftr
defect
protein
patient
cf
appear
play
role
neuropeptid
secret
cftr
knockout
mice
contain
fewer
pulmonari
neuroendocrin
cell
embryon
develop
increas
number
cell
birth
observ
suggest
endogen
airway
progenitor
cell
pathway
cf
lung
may
alter
extens
investig
clarifi
alveolar
epitheli
repar
potenti
remain
center
atii
cell
longheld
concept
atii
cell
precursor
type
alveolar
epitheli
ati
cell
howev
recent
data
suggest
sever
popul
distal
airway
epitheli
progenitor
cell
mice
includ
basc
cell
contribut
repair
damag
alveoli
neonat
mice
popul
put
progenitor
cell
express
ccsp
stem
cell
antigen
stagespecif
embryon
antigen
identifi
cell
abl
form
epitheli
coloni
differenti
ati
atii
cell
howev
lineag
relationship
atii
ati
cell
requir
clarif
particularli
ati
cell
mitot
vitro
addit
studi
need
resolv
controversi
sever
studi
suggest
endogen
lung
epitheli
progenitor
cell
may
target
environment
agent
includ
pneumotroph
pathogen
airway
stem
progenitorlik
cell
mice
suscept
infect
sever
acut
respiratori
syndrom
influenza
virus
rais
possibl
endogen
lung
progenitor
cell
may
specif
diseas
target
compar
basal
epitheli
cell
trachea
upper
airway
appear
suscept
infect
common
cold
rhinoviru
howev
respiratori
virus
target
wide
rang
respiratori
epitheli
cell
addit
progenitor
cell
endogen
progenitor
cell
may
also
attract
candid
target
gene
transfer
vector
provid
sustain
express
exampl
intratrach
administ
recombin
adenoassoci
vector
may
preferenti
target
vce
adult
mice
wherea
recombin
lentiviru
vector
administ
amniot
fluid
appear
preferenti
target
airway
progenitor
fetal
mous
lung
major
challeng
remain
endogen
lung
progenitor
field
continu
area
develop
includ
identif
adequ
cellspecif
marker
sophist
lineagetrac
tool
increas
explor
progenitor
vascular
stromal
lung
compart
function
assay
put
endogen
progenitor
cell
popul
exist
cell
typespecif
marker
particular
need
refin
increas
knowledg
obtain
inher
plastic
lung
cell
type
previous
identifi
lineag
deconstruct
adequ
approach
must
develop
studi
human
lung
increas
collabor
cross
fertil
must
occur
reconcil
differ
terminolog
methodolog
use
differ
laboratori
exampl
disagr
lack
consist
interpret
applic
seemingli
straightforward
terminolog
differenti
versu
undifferenti
special
versu
unspeci
continu
imped
progress
list
suggest
terminolog
illustr
tabl
accompani
confer
report
like
need
revis
near
futur
intens
interest
connect
endogen
lung
stem
progenitor
cell
cancer
stem
cell
cancer
stem
cell
defin
transplant
assay
cell
subset
capabl
propag
diseas
cell
vermont
stem
cell
confer
frequent
term
tumor
initi
cell
hypothes
cell
maintain
tumor
progress
diseas
resist
cancer
stem
cell
best
describ
leukemia
breast
cancer
brain
cancer
increas
evid
suggest
lung
cancer
may
contain
rare
popul
cancer
stem
cell
review
refer
studi
suggest
differ
type
lung
cancer
initi
distinct
cell
type
lung
tumoriniti
cell
may
may
ident
cancer
stem
cell
maintain
establish
tumor
given
divers
lung
cancer
subtyp
may
surpris
purif
character
tumoriniti
cell
andor
cancer
stem
cell
import
aspect
studi
design
test
cancer
stem
cell
hypothesi
older
studi
review
refer
shown
side
popul
cell
identifi
sever
human
lung
cancer
cell
line
exhibit
tumorigen
properti
subcutan
implant
nonobes
diabet
scid
mice
side
popul
cell
also
identifi
clinic
lung
cancer
specimen
dualposit
prospcccsp
posit
cell
basc
discuss
section
also
suggest
tumoriniti
cell
number
recent
report
implic
cell
confer
resist
chemotherapi
tumoriniti
properti
aldehyd
dehydrogenas
activ
express
oncofet
protein
also
suggest
marker
lung
cancer
stem
cell
studi
review
refer
recent
studi
begun
elucid
cell
signal
gene
express
pathway
includ
pten
protein
kinas
c
iota
wnt
hedgehog
ckit
akt
matrix
metalloproteinas
other
may
play
role
transform
endogen
progenitor
cell
lung
cancer
cell
despit
grow
data
work
need
clarifi
connect
endogen
lung
progenitor
cell
potenti
role
lung
cancer
stem
cell
importantli
potenti
role
therapeut
target
studi
evalu
embryon
stem
cell
esc
induc
pluripot
stem
cell
ipsc
lung
regener
repair
shown
promis
recent
progress
sever
laboratori
initi
demonstr
mous
human
esc
could
induc
cultur
acquir
phenotyp
marker
atii
cell
includ
express
surfact
protein
lamellar
bodi
even
form
pseudoglandular
structur
review
howev
gener
occur
low
level
unless
esc
transduc
select
cell
express
antibiot
resist
cassett
regulatori
control
surfact
proteinc
promot
fragment
never
clear
deriv
cell
acquir
appropri
function
alveolar
cell
recent
protocol
incorpor
sophist
understand
applic
cell
signal
pathway
guid
embryolog
lung
develop
develop
definit
endoderm
well
newli
develop
lineag
trace
tool
express
mice
yield
robust
vitro
deriv
cell
phenotyp
characterist
type
type
alveolar
epitheli
cell
murin
human
esc
ipsc
figur
investig
function
aspect
escderiv
lung
cell
abil
repopul
decellular
lung
scaffold
increasingli
incorpor
figur
recent
cultur
protocol
also
robustli
suggest
develop
cell
phenotyp
characterist
airway
cell
includ
deriv
ipsc
obtain
patient
cf
provid
solid
basi
studi
esc
ipsc
genet
lung
diseas
cf
figur
grow
number
studi
suggest
effect
matrix
protein
threedimension
scaffold
mechan
forc
cultur
system
eg
use
rotat
bioreactor
play
critic
role
further
understand
mean
esc
ipsc
might
induc
acquir
phenotyp
function
airway
alveolar
epitheli
cell
littl
data
avail
develop
lung
pulmonari
vasculatur
stroma
cultur
esc
ipsc
american
thorac
societi
issu
statement
call
expand
human
embryon
stem
cell
research
followup
statement
temporari
injunct
use
human
stem
cell
unit
state
hope
human
embryon
induc
pluripot
stem
cell
research
continu
expand
unit
state
rapid
advanc
studi
esc
lung
injuri
repair
award
nobel
prize
medicin
shinya
yamanaka
pioneer
develop
ipsc
technolog
underscor
import
attribut
technolog
gener
diseasespecif
human
ipsc
line
patient
genet
acquir
lung
diseas
includ
cf
diseas
sickl
cell
scleroderma
provid
opportun
use
ipsc
studi
lung
diseas
grow
number
public
assess
effect
vivo
administr
esc
ip
cell
sever
subpopul
cell
differenti
vitro
human
esc
includ
express
angiotensinconvert
enzym
mesoderm
induct
express
endoderm
induct
mous
model
silica
sepsi
bleomycininduc
lung
injuri
whether
observ
amelior
lung
injuri
result
structur
engraft
administ
cell
reflect
previous
unsuspect
paracrin
effect
escsor
ipsc
includ
interact
immun
effector
cell
unknown
mechan
action
clear
care
studi
includ
elucid
ration
biolog
role
esc
ipsc
cell
amelior
lung
injuri
need
done
epc
defin
past
decad
circul
bmderiv
cell
express
varieti
cell
surfac
marker
compar
express
vascular
endotheli
cell
adher
endothelium
site
hypoxiaischemia
prolifer
particip
new
vessel
format
review
increas
evid
demonstr
epc
play
role
pathogenesi
wide
varieti
lung
diseas
includ
pulmonari
hypertens
pulmonari
fibrosi
asthma
copd
acut
lung
injuri
ali
lung
cancer
bronchopulmonari
dysplasia
obstruct
sleep
apnea
children
review
refer
recent
articl
review
howev
studi
epc
lung
diseas
hamper
lack
consensu
regard
identif
cell
although
specif
marker
circul
epc
identifi
panel
flow
cytometri
marker
conjunct
immunostain
use
identifi
enumer
cell
bm
circul
howev
even
similar
techniqu
use
differ
report
differ
group
marker
use
differ
data
acquisit
analysi
significantli
alter
studi
interpret
lack
uniqu
cell
surfac
marker
identifi
epc
continu
complic
compar
assess
pulmonari
diseas
process
result
grow
consensu
field
encourag
use
function
assay
vitro
vivo
conjunct
use
flow
cytometri
immunohistochemistri
enumer
epc
also
better
character
true
abil
form
function
endothelium
critic
area
futur
studi
remain
develop
consensusbas
approach
definit
use
epc
particular
emphasi
function
capabl
cell
number
hematopoiet
vascular
endotheli
cell
subset
display
similar
cell
surfac
epitop
may
deriv
discrimin
extens
gene
express
analysi
use
varieti
function
assay
interact
hematopoiet
stem
cell
endotheli
progenitor
cell
gener
mainten
repair
vasculatur
becom
increasingli
complex
hematopoiet
stem
cell
describ
potenti
contribut
hemogen
vascular
endothelium
endothelium
contribut
deriv
hematopoiet
lineag
dysregul
process
increasingli
recogn
contribut
vascular
diseas
includ
pulmonari
hypertens
patholog
condit
includ
asthma
exampl
immunodefici
mice
transplant
bmderiv
progenitor
cell
obtain
patient
pulmonari
hypertens
develop
patholog
featur
pulmonari
hypertens
contrast
progenitor
cell
appear
contribut
vascular
growth
postpneumonectomi
lung
regener
mice
addit
circul
epc
sever
popul
vascular
progenitor
cell
resid
differ
segment
pulmonari
vasculatur
recent
identifi
character
cell
function
regul
contribut
pulmonari
vascular
diseas
area
intens
current
studi
number
circul
epc
correl
sever
clinic
variabl
differ
lung
diseas
demonstr
potenti
util
epc
biomark
review
refer
recent
articl
review
refer
increas
circul
epc
number
correl
surviv
ali
acut
respiratori
distress
syndrom
ard
associ
less
residu
lung
damag
patient
pneumonia
invers
associ
organ
dysfunct
sepsi
increas
number
circul
epc
patient
copd
associ
abnorm
spirometri
although
differ
studi
shown
level
circul
epc
invers
correl
copd
diseas
sever
particularli
associ
decreas
bodi
mass
index
necessarili
diseas
exacerb
increas
number
circul
epc
also
portend
wors
surviv
among
nonsmal
cell
lung
cancer
subject
asthma
number
circul
epc
increas
compar
nonasthmat
control
subject
correl
clinic
outcom
epc
recruit
airway
patient
asthma
allergen
challeng
correl
increas
number
diamet
blood
vessel
observ
lung
tissu
biopsi
obtain
hour
challeng
decreas
number
circul
epc
cord
blood
also
describ
infant
later
develop
bronchopulmonari
dysplasia
sever
clinic
factor
implic
mobil
epc
lung
diseas
mechan
effect
begun
elucid
hypoxia
appear
stimulu
epc
mobil
recruit
wherea
hyperoxia
correl
decreas
circul
epc
particularli
preterm
infant
featur
may
play
role
bronchopulmonari
dysplasia
disord
prematur
infant
neonat
expos
high
oxygen
level
observ
also
suggest
epc
could
contribut
lung
repair
ali
defect
lung
develop
defect
lung
repair
set
protract
inflamm
injuri
may
result
part
inadequ
contribut
local
circul
epc
age
report
invers
correl
epc
number
abil
epc
home
ischem
tissu
may
mediat
inabl
age
tissu
normal
activ
hypoxiainduc
hypoxia
respons
use
hmgcoa
reductas
inhibitor
demonstr
benefici
effect
mobil
epc
may
relat
effect
class
drug
prevent
epc
apoptosi
respons
noxiou
stimuli
includ
effect
tnfa
therebi
enhanc
epc
surviv
differenti
review
refer
pathway
recent
implic
mobil
epc
includ
circul
vegf
insulinlik
growth
factor
chemokin
howev
increas
number
circul
epc
develop
method
enhanc
mobil
may
appropri
diseas
affect
lung
particularli
lung
cancer
epc
may
effect
develop
lung
tumor
vasculatur
home
site
lung
metastas
cancer
neovascular
involv
recruit
epc
bm
potenti
contribut
endogen
endotheli
cell
pulmonari
vasculatur
cell
logic
target
antiangiogenesi
therapi
addit
system
inject
epc
local
lung
appear
home
metastat
tumor
lung
yet
poorli
understood
mechan
suggest
modif
epc
express
suicid
gene
therapeut
molecul
could
potenti
use
cellbas
therapi
approach
lung
cancer
mechan
control
mobil
home
epc
lung
remain
poorli
understood
subject
intens
investig
increas
number
studi
demonstr
system
administr
epc
mitig
experiment
induc
lung
injuri
preclin
rodent
dog
model
pulmonari
hypertens
review
refer
endotoxininduc
ali
bronchopulmonari
dysplasia
whether
includ
structur
contribut
administ
cell
paracrin
stimul
endogen
vascular
progenitor
cell
paracrin
immunomodulatori
action
remain
unclear
combin
effect
may
occur
differ
diseas
state
epc
transduc
express
proangiogen
factor
endotheli
nitric
oxid
synthetas
eno
inhibitor
smooth
muscl
cell
prolifer
calcitonin
generel
peptid
appear
home
site
endotheli
damag
lung
injuri
epc
also
preferenti
local
area
injur
lung
system
administr
may
paracrin
effect
decreas
inflamm
find
gener
sever
clinic
investig
epc
administr
pulmonari
hypertens
discuss
clarif
specif
cell
type
involv
process
neoangiogenesi
better
phenotyp
marker
function
assay
result
less
confus
surround
term
epc
elucid
progenitor
cell
resid
vasculatur
role
circul
vasculogen
cell
lung
develop
repair
injuri
focu
extens
current
investig
potenti
role
exogen
administ
vasculogen
cell
either
unmodifi
engin
express
angiogen
factor
show
increas
promis
sever
type
lung
injuri
must
consid
cautious
given
potenti
deleteri
role
lung
cancer
circul
fibrocyt
first
describ
subset
circul
leukocyt
produc
collagen
home
site
inflamm
cell
character
express
cell
surfac
marker
mhc
ii
also
express
type
collagen
fibronectin
circul
fibrocyt
implic
pathogenesi
sever
lung
diseas
includ
mous
clinic
model
pulmonari
fibrosi
pulmonari
hypertens
subepitheli
fibrosi
develop
sever
asthma
sickl
cell
lung
diseas
clinic
bronchiol
obliteran
patient
undergo
lung
bm
transplant
older
articl
review
refer
recent
articl
review
recent
articl
continu
demonstr
elev
level
circul
fibrocyt
suggest
indic
wors
prognosi
idiopath
pulmonari
fibrosi
pulmonari
hypertens
develop
bronchiol
obliteran
lung
transplant
number
circul
fibrocyt
highest
patient
experienc
acut
ipf
exacerb
number
return
baselin
recoveri
content
fibrocyt
bronchoalveolar
lavag
fluid
also
recent
suggest
predictor
wors
outcom
patient
ali
sever
cytokin
chemokin
pathway
includ
stromal
deriv
axi
action
axi
axe
egf
receptor
signal
tgfb
receptor
signal
implic
recruit
subsequ
prolifer
circul
fibrocyt
fibrot
lung
overal
mechan
fibrocyt
recruit
lung
poorli
understood
serum
amyloid
protein
surfact
protein
haptoglobin
cysteinyl
leukotrien
tgfb
receptor
signal
hypoxia
also
implic
fibrocyt
recruit
differenti
recent
studi
demonstr
prostacyclin
analog
treprostonil
inhibit
recruit
circul
fibrocyt
model
chronic
hypoxiainduc
pulmonari
hypertens
mice
matrix
metalloproteinas
express
may
also
involv
recruit
fibrocyt
injur
posttranspl
lung
viral
infect
suggest
increas
recruit
prolifer
fibrocyt
injur
lung
nfkbmediat
express
tgfb
cysteinyl
leukotrienemedi
pathway
studi
definit
proven
fibrocyt
differenti
fibroblast
vivo
clear
whether
profibrot
action
paracrin
via
direct
differenti
fibroblastsmyofibroblast
regard
potenti
paracrin
action
recent
studi
demonstr
fibrocyt
patient
ipf
overexpress
periostin
matricellular
protein
help
activ
lysyl
oxidas
stiffen
extracellular
matric
circul
fibrocyt
may
also
import
lung
cancer
develop
metastasi
circul
fibrocyt
precursor
found
blood
lung
cancer
patient
contribut
tumor
develop
system
administ
nonobes
diabet
scid
mice
engraft
human
lung
cancer
xenograft
bone
marrowderiv
cell
may
also
contribut
fibroblast
myofibroblast
tumor
stromal
tissu
result
suggest
specif
inhibit
fibrocyt
use
drug
deliveri
vehicl
may
import
therapeut
target
pulmonari
vascular
diseas
two
differ
popul
cell
isol
human
amniot
tissu
human
amniot
epitheli
cell
haec
heterogen
popul
multipot
cell
term
human
amniot
fluid
stem
cell
hafsc
describ
appar
engraft
limit
amount
mous
lung
potenti
efficaci
lung
injuri
amnion
deriv
embryon
epiblast
gastrul
amniot
cell
may
retain
capac
differenti
three
embryon
lineag
cell
deriv
lineag
addit
number
recent
public
demonstr
hafsc
may
immunomodulatori
properti
compar
observ
msc
obtain
tissu
sourc
hafsc
obtain
amniot
fluid
aspir
contain
mix
popul
mesenchym
stromal
epitheli
cell
microinject
fetal
mous
lung
ckit
subfract
human
hafsc
local
distal
airway
express
spc
system
administr
hyperoxiaor
naphthaleneinjur
adult
mice
result
local
express
characterist
alveolar
airway
epitheli
marker
respect
administr
ckit
hafsc
also
amelior
experiment
induc
kidney
injuri
immunodefici
mice
popul
hafsc
appear
featur
common
msc
isol
tissu
exampl
system
administr
hafsc
amelior
monocrotalineinduc
pulmonari
hypertens
rat
hafsc
also
stimul
recruit
host
progenitor
cell
function
tissu
repair
recent
report
suggest
hafsc
might
induc
express
cftr
cocultur
cf
airway
epitheli
cell
purifi
popul
haec
express
capac
differenti
number
lineag
also
immunomodulatori
properti
haec
also
exhibit
low
immunogen
combin
antiinflammatori
properti
led
clinic
use
burn
wound
repair
ophthalmalog
applic
sever
recent
paper
demonstr
efficaci
purifi
amniot
epitheli
cell
popul
mix
popul
stromal
epitheli
cell
deriv
digest
amnion
membran
mous
sheep
model
endotoxinor
bleomycininduc
lung
injuri
lowlevel
engraft
modul
intrins
inflammatori
cell
propos
mechan
recent
report
demonstr
condit
medium
amniot
fluidderiv
msc
mitig
bleomycininduc
lung
injuri
although
administr
purifi
haec
bleomycininjur
immunocompet
mice
result
abrog
lung
injuri
without
appar
host
respons
cell
acut
inflammatori
respons
observ
use
allogen
mous
xenogen
human
amniot
cell
bleomycininjur
mice
mani
factor
consid
use
amnion
cell
includ
underli
medic
condit
mother
develop
fetu
gestat
age
thu
although
promis
result
obtain
investig
warrant
mechanist
potenti
translat
applic
cell
deriv
amnion
placent
tissu
use
lung
repair
regener
msc
first
describ
adher
clonogen
nonphagocyt
fibroblasticlik
popul
bm
cell
review
nomenclatur
chang
year
msc
initi
term
fibroblast
colonyform
unit
subsequ
marrow
stromal
cell
mesenchym
stem
cell
mesenchym
stromal
cell
multipot
mesenchym
stromal
cell
consist
literatur
particularli
applic
commonli
current
use
term
mesenchym
stem
cell
mesenchym
stromal
cell
part
depend
whether
msc
use
abil
differenti
lineag
potenti
use
regen
medicin
effort
structur
repair
differenti
tradit
osteoblast
chondrocyt
adipocyt
lineag
lineag
includ
epitheli
cell
immunomodulatori
properti
msc
absenc
structur
engraft
latter
area
substant
progress
continu
made
understand
mechan
msc
immunomodulatori
action
increas
possibl
use
msc
treat
lung
diseas
definit
investig
msc
continu
confound
sever
issu
detail
previou
confer
report
number
review
signific
differ
msc
isol
differ
speci
differ
strain
within
given
speci
regardless
actual
tissu
sourc
msc
includ
properti
cell
surfac
epitop
secretom
immunomodulatori
action
genom
stabil
human
msc
deriv
bm
best
character
msc
continu
present
challeng
featur
furthermor
although
msc
isol
differ
tissu
sourc
includ
bm
adipos
cord
blood
placenta
gener
express
compar
cell
surfac
marker
differenti
along
recogn
lineag
pathway
differ
gene
express
lineag
tendenc
properti
describ
investig
function
differ
msc
isol
differ
sourc
area
current
intens
investig
clear
whether
one
given
sourc
origin
msc
prove
superior
amelior
specif
diseas
includ
lung
diseas
epc
mani
publish
studi
use
differ
isol
purif
approach
grow
evid
msc
heterogen
differ
msc
subtyp
exist
part
exemplifi
observ
parallel
prepar
msc
human
bm
aspir
isol
normal
donor
session
differ
featur
propag
rate
differenti
potenti
continu
complic
compar
assess
publish
studi
mesenchym
tissu
stem
cell
committe
intern
societi
cellular
therapi
defin
minim
criteria
defin
human
msc
criteria
updat
given
continu
advanc
understand
msc
biolog
particular
focu
develop
potenc
assay
applic
clinic
applic
new
framework
understand
use
nomenclatur
definit
character
msc
recent
suggest
tabl
becom
increasingli
clear
surround
physic
environ
profoundli
affect
msc
behavior
cultur
variabl
includ
cultur
surfac
composit
stiff
mechan
forc
temperatur
cultur
densiti
profoundli
influenc
phenotyp
behavior
msc
older
articl
review
refer
recent
articl
review
stiff
mechan
forc
particular
increasingli
recogn
critic
factor
direct
msc
differenti
behavior
effect
ambient
oxygen
environ
recent
clarifi
becom
appar
hypox
condit
may
prefer
cultur
manipul
msc
address
variat
properti
cultur
msc
nation
center
research
resourcesn
institut
health
sponsor
center
prepar
distribut
adult
stem
cell
msc
serv
preclin
resourc
standard
prepar
mous
rat
human
msc
http
medicinetamhsceduirmmscdistribut
html
nation
heart
lung
blood
institut
also
sponsor
pact
product
assist
cellular
therapi
program
train
good
manufactur
practic
resourc
support
preclin
investig
new
drug
prepar
clinic
investig
msc
cell
therapi
http
secureemmescompactwebfacil
cell
phenotyp
characterist
msc
isol
adult
mous
lung
human
nasal
mucosa
lung
human
neonat
human
lung
transplant
recipi
review
refer
human
lung
msc
lmsc
share
similar
gene
express
appear
immunomodulatori
capabl
similar
bmderiv
msc
function
role
lmsc
incomplet
understood
grow
evid
suggest
role
fibrot
diseas
pathogenesi
bronchiol
obliteran
lung
transplant
ovalbumin
sensit
challeng
increas
number
lmsc
mous
lung
lmsc
may
influenc
tregulatori
cell
activ
bleomycininduc
lung
fibrosi
mice
observ
suggest
lung
msc
may
involv
regul
local
inflammatori
immun
respons
lmsc
homeostat
regul
influenc
migrat
engraft
epitheli
cell
differenti
also
well
understood
multipot
progenitor
stromal
cell
popul
describ
lung
speci
ident
role
cell
well
understood
number
studi
demonstr
system
msc
administr
cell
initi
local
lung
vascular
bed
lung
injuri
result
increas
local
andor
retent
bmderiv
cell
lung
review
refer
whether
repres
format
cell
emboli
lung
vasculatur
specif
adher
pulmonari
vascular
adhes
molecul
remain
unclear
furthermor
sourc
msc
may
influenc
retent
lung
exampl
msc
deriv
human
umbil
cord
blood
clear
rapidli
lung
human
bmderiv
msc
reflect
differ
size
msc
differ
sourc
differenti
express
specif
integrin
proteoglycan
pattern
retent
lung
may
also
trigger
msc
function
effect
exampl
embol
system
administ
msc
lung
felt
result
secret
antiinflammatori
protein
furthermor
although
bm
adiposederiv
msc
induc
vitro
express
phenotyp
marker
alveolar
airway
epitheli
cell
engraft
msc
lung
epithelium
cell
type
investig
far
rare
event
uncertain
physiolog
signific
lung
howev
avail
data
suggest
system
administ
msc
engraft
fibroblast
myfibroblast
certain
injuri
condit
discuss
increas
focu
immunomodulatori
antiinflammatori
properti
msc
figur
msc
exist
pericyt
line
vascular
bed
increasingli
believ
sampl
accordingli
modul
local
environ
counter
inflammatori
immun
stimuli
bm
serv
provid
nich
hematopoiet
stem
cell
differenti
msc
secret
multipl
regulatori
molecul
growth
factor
antiinflammatori
cytokin
modul
immun
inflammatori
respons
review
refer
msc
also
inhibit
prolifer
function
broad
rang
immun
cell
includ
cell
b
cell
natur
killer
cell
neutrophil
macrophag
dendrit
cell
vitro
model
system
review
refer
msc
inhibit
lymphocyt
prolifer
activ
cytokin
releas
respons
alloantigen
mitogen
stimuli
dosedepend
direct
suppress
effect
prolifer
msc
also
influenc
macrophag
phenotyp
mani
case
promot
antiinflammatori
phenotyp
mechan
msc
action
immun
effector
cell
prolifer
function
partli
understood
direct
cellcel
contact
releas
solubl
mediat
propos
msc
also
act
antigenpres
cell
vitro
model
system
properti
influenc
exposur
ifng
tgfb
rapidli
grow
bodi
data
suggest
releas
episom
microsom
particl
msc
influenc
behavior
surround
structur
cell
surround
inflammatori
cell
msc
also
recent
demonstr
form
direct
link
cell
exampl
connexin
bridg
transfer
mitochondria
like
cytosol
compon
although
physiolog
repair
role
cellcel
link
elucid
recent
data
demonstr
result
replenish
atpdeplet
recipi
cell
also
becom
increasingli
clear
differ
inflammatori
environ
profoundli
influenc
msc
behavior
result
signific
chang
immunomodulatori
properti
potenti
immunogen
msc
respect
lung
diseas
exampl
msc
express
wide
varieti
chemokin
cytokin
receptor
includ
tnfa
ifng
cytokin
increas
differ
lung
injuri
express
mhc
costimulatori
molecul
alter
exposur
inflammatori
mediat
commonli
found
vivo
ifng
tgfb
chemotaxi
migrat
toward
wide
varieti
tabl
although
ideal
term
term
mesenchym
stem
cell
use
specif
describ
cell
document
selfrenew
differenti
characterist
msc
categor
cultur
primari
import
distinct
see
characterist
like
differ
avoid
confus
comparison
made
studi
sourc
msc
specifi
eg
adipos
bone
marrow
cord
blood
etc
differ
cell
characterist
like
encount
speci
identifi
inform
alway
explicitli
state
text
public
except
method
section
led
confus
past
mediat
includ
stromal
deriv
tnfa
macrophag
migrat
inhibitori
factor
tgfb
hepatocyt
growth
factor
hgf
other
describ
review
msc
also
express
tolllik
receptor
includ
endotoxin
receptor
activ
produc
wide
varieti
effect
mani
still
elucid
express
tlr
msc
influenc
number
factor
includ
exposur
bacteri
toxin
varieti
inflammatori
mediat
hypoxia
characterist
mani
lung
injuri
diseas
also
alter
msc
express
cell
surfac
molecul
secret
solubl
mediat
msc
overal
rapidli
grow
bodi
evid
demonstr
msc
malleabl
significantli
influenc
local
inflammatori
environ
includ
found
lung
injuri
also
offer
potenti
opportun
manipul
msc
ex
vivo
optim
potenti
clinic
use
exampl
condit
media
obtain
msc
expos
ex
vivo
hyperoxia
better
abl
amelior
hyperoxiainduc
lung
injuri
rodent
model
compar
condit
media
obtain
msc
cultur
normoxia
msc
grown
routin
tissu
cultur
condit
exhibit
low
constitut
express
major
histocompat
complex
mhc
class
lack
constitut
express
mhc
class
ii
costimulatori
molecul
review
parallel
administr
nonhlamatch
allogen
msc
appear
feasibl
safe
howev
msc
like
influenc
local
inflammatori
environ
express
cell
surfac
epitop
may
trigger
recogn
host
immun
system
might
affect
msc
action
vivo
clear
although
frequenc
msc
adult
bm
low
isol
bm
tissu
msc
expand
ex
vivo
make
possibl
manufactur
cell
potenti
therapeut
purpos
overal
properti
msc
make
attract
potenti
therapeut
tool
vector
deliveri
diseasespecif
treatment
substanc
immunomodulatori
agent
howev
care
consider
must
given
initi
msc
heterogen
subsequ
clonal
heterogen
overal
mean
cultur
expans
recent
data
suggest
freshli
thaw
cryopreserv
msc
may
effect
cell
allow
recov
administr
may
signific
ramif
design
clinic
investig
use
msc
steadili
increas
number
articl
demonstr
efficaci
system
intratrach
msc
administr
grow
spectrum
lung
injuri
model
rodent
anim
model
explant
human
lung
slowli
grow
number
clinic
investig
lung
diseas
review
refer
includ
rodent
anim
model
ali
bacteri
lung
infect
asthma
bronchiol
obliteran
bronchopulmonari
dysplasia
copd
pulmonari
ischemia
reperfus
injuri
obstruct
sleep
apnea
pulmonari
fibrosi
pulmonari
hypertens
radiationinduc
lung
injuri
sepsi
burn
critic
ill
autoimmunerel
lung
injuri
includ
hemorrhag
shock
pancreat
silicosi
ventilatorinduc
lung
injuri
articl
publish
summar
tabl
older
articl
summar
correspond
tabl
previou
confer
report
system
administ
msc
also
home
tumor
yet
unclear
mechan
use
deliveri
chemotherapeut
antitumor
agent
mous
lung
tumor
model
may
provid
viabl
therapi
lung
cancer
particularli
msc
engin
express
tumor
necrosi
factorrel
apoptosi
induc
ligand
ifnb
administr
msc
bm
placent
origin
also
demonstr
decreas
injuri
inflamm
endotoxin
bacteri
injur
injur
human
lung
explant
howev
msc
may
alway
amelior
lung
injuri
avail
preclin
data
suggest
msc
may
contribut
lung
fibrosi
although
mechan
msc
effect
complet
understood
solubl
mediat
releas
msc
appear
play
import
role
differ
model
implic
differ
model
system
includ
angiopoietin
adiponectin
receptor
antagonist
hgf
keratinocyt
growth
factor
kgf
tgfb
figur
transduct
transfect
msc
overexpress
secret
mediat
includ
kgf
knockdown
use
sirna
approach
decreas
endotoxinmedi
lung
injuri
presum
abrog
endotoxinmedi
endotheli
injuri
transduc
msc
overexpress
eno
kgf
inhibitor
found
effect
prevent
monocrotalineinduc
pulmonari
hypertens
ischemiareperfusioninduc
lung
injuri
bleomycininduc
pulmonari
inflamm
subsequ
fibrosi
respect
msc
appear
also
act
part
decreas
increas
endotheli
permeabl
found
ali
secret
antibacteri
peptid
promot
antiinflammatori
phenotyp
alveolar
macrophag
increas
monocyt
phagocyt
activ
mitochondri
transfer
msc
atii
cell
demonstr
replenish
endotoxindeplet
atp
store
restor
surfact
secret
grow
number
report
suggest
administr
condit
media
obtain
msc
may
mimic
mani
amelior
effect
result
msc
administr
differ
lung
injuri
model
part
may
reflect
action
exosom
microsom
particl
releas
msc
howev
specif
mediat
solubl
protein
exosom
ahav
clarifi
like
differ
lung
injuri
model
figur
recent
report
suggest
msc
may
also
promot
repair
activ
endogen
distal
lung
airway
progenitor
cell
popul
mous
model
msc
also
exert
effect
lung
inflamm
injuri
primari
interact
immun
system
rather
direct
action
lung
exampl
grow
bodi
evid
suggest
msc
amelior
allerg
airway
inflamm
mice
increas
tregulatori
cell
promot
phenotyp
vivo
antigenspecif
cell
circul
antigenspecif
immunoglobulin
mean
abrog
lung
injuri
msc
appear
capabl
spectrum
effect
differ
lung
injuri
critic
ill
critic
import
point
clinic
use
msc
must
tailor
toward
specif
diseas
process
mani
studi
discuss
use
differ
prepar
msc
detail
recent
public
tabl
rang
popul
heterogen
plastic
adher
adipos
stromal
cell
purifi
wellcharacter
bmderiv
msc
obtain
core
facil
ncrrnih
sponsor
texa
formerli
tulan
center
prepar
distribut
adult
stem
cell
msc
http
medicinetamhscedu
irmmscdistributionhtml
studi
vermont
stem
cell
confer
vermont
stem
cell
confer
directli
compar
differ
msc
prepar
lung
diseas
model
one
avail
comparison
studi
human
chorion
tissuederiv
msc
effect
human
bmderiv
msc
mitig
endotoxininduc
inflamm
explant
human
lung
contrast
mous
adiposederiv
msc
effect
human
adipos
msc
amelior
endotoxininduc
lung
injuri
mice
differ
sourc
msc
immedi
clinic
implic
sever
clinic
investig
plan
underway
lung
diseas
use
msc
obtain
adipos
placent
tissu
well
bm
howev
whether
cell
differ
tissu
sourc
behav
differ
differ
clinic
lung
diseas
remain
poorli
defin
addit
preclin
clinic
comparison
studi
necessari
differ
syngen
allogen
xenogen
msc
administr
less
well
explor
preclin
lung
injuri
model
grow
number
studi
demonstr
efficaci
human
msc
lung
injuri
model
immunedefici
immunecompet
mice
howev
recent
headtohead
comparison
human
msc
amelior
bleomycininduc
lung
injuri
immunedefici
versu
immunecompet
mice
suggest
human
msc
may
less
effect
immunecompet
mice
although
overal
consist
studi
demonstr
abil
msc
amelior
differ
type
lung
injuri
encourag
continu
rigor
must
appli
understand
mechan
msc
effect
compar
msc
isol
differ
protocol
obtain
differ
sourc
furthermor
specif
msc
effect
compar
potenti
antiinflammatori
immunomodulatori
effect
stromal
cell
eg
fibroblast
must
care
consid
exampl
system
administr
primari
dermal
fibroblast
similarli
decreas
ragwe
pollenor
ovalbumininduc
allerg
airway
inflamm
compar
msc
administr
fibroblast
transduc
express
decreas
acut
endotoxininduc
lung
injuri
howev
intratrach
administr
fibroblast
mimic
effect
msc
amelior
endotoxininduc
ali
review
refer
result
suggest
msc
stromal
cell
eg
fibroblast
may
share
similar
antiinflammatori
mechan
howev
fibroblast
also
heterogen
depend
part
tissu
sourc
thu
potenti
antiinflammatori
effect
may
differ
depend
origin
furthermor
fibroblast
less
like
degre
low
immunogen
msc
provok
lung
inflamm
nonetheless
comparison
msc
fibroblast
differ
injuri
model
like
provid
import
insight
antiinflammatori
mechan
msc
import
includ
appropri
cell
control
eg
fibroblast
assess
msc
effect
differ
lung
injuri
model
cell
popul
increasingli
describ
amelior
effect
mous
model
lung
injuri
sepsi
includ
human
amniot
fluid
amnionderiv
epitheli
cell
grow
bodi
literatur
also
describ
effect
heterogen
popul
bmderiv
mononuclear
cell
amelior
injuri
mous
model
ali
allerg
airway
inflamm
copd
hemorrhag
shock
sepsi
silicosi
bmderiv
mononuclear
cell
fraction
contain
msc
clear
whether
msc
fraction
respons
observ
effect
use
bmderiv
mononuclear
fraction
suggest
potenti
conveni
mean
autolog
cell
therapi
lung
diseas
bm
cell
harvest
prepar
administ
even
day
avoid
step
necessari
isol
purif
expans
involv
use
msc
well
consider
msc
use
discuss
howev
unclear
whether
bm
mononuclear
cell
includ
msc
harvest
individu
differ
lung
diseas
appropri
function
use
mitig
specif
lung
injuri
use
autolog
bm
cell
also
potenti
problemat
light
medic
tourism
issu
discuss
sever
report
describ
amelior
ali
bleomycininduc
fibrosi
sepsisinduc
lung
injuri
silicosi
mous
model
administr
embryon
stem
cell
induc
pluripot
cell
epitheli
progenitor
cell
human
cord
bloodderiv
hematopoiet
progenitor
cell
atii
cell
vari
level
engraft
differ
cell
type
describ
differ
publish
report
suggest
potenti
paracrin
immunomodulatori
effect
primari
mechan
action
unclear
cell
would
immunomodulatori
effect
much
character
clarif
requir
continu
rapidli
grow
area
investig
use
threedimension
matric
artifici
scaffold
growth
function
tracheal
lung
tissu
stem
progenitor
cell
ex
vivo
vivo
approach
increasingli
success
use
regener
tissu
includ
skin
vasculatur
cartilag
bone
recent
complex
organ
includ
heart
liver
signific
progress
continu
made
trachea
use
synthet
scaffold
decellular
cadaver
donor
trachea
type
scaffold
seed
stromal
andor
epitheli
cell
deriv
eventu
recipi
result
growth
tissu
resembl
normal
trachea
number
differ
synthet
scaffold
materi
cytokin
growth
factor
investig
use
promot
cell
growth
scaffold
optim
compon
combin
clear
grow
investig
patient
treat
tracheal
replac
use
decellular
artifici
trachea
shown
promis
yet
mix
result
compar
progress
occur
use
natur
synthet
scaffold
larynx
diaphragm
anticip
initi
clinic
investig
occur
rel
near
futur
given
complex
threedimension
architectur
structurefunct
relationship
lung
formid
task
nonetheless
signific
progress
sever
area
threedimension
cultur
system
investig
number
year
matric
ex
vivo
lung
parenchym
develop
studi
growth
factor
mechan
forc
lung
remodel
studi
includ
implant
variou
scaffold
impregn
stem
cell
produc
function
lung
tissu
compar
scaffold
approach
use
studi
creation
pulmonari
vascular
network
investig
effect
vascular
endotheli
cell
develop
airway
alveolar
epitheli
tissu
studi
demonstr
power
threedimension
cultur
system
use
synthet
scaffold
evalu
lung
develop
repair
ex
vivo
vivo
howev
artifici
scaffold
fulli
replic
complex
lung
architectur
contain
matrix
compon
essenti
normal
lung
develop
function
rapidli
grow
bodi
recent
work
focus
use
natur
model
includ
nasal
septa
decellular
whole
lung
physiolog
scaffold
nativ
structur
lung
relev
extracellular
matrix
ecm
compon
includ
collagen
fibronectin
laminin
left
intact
remov
cellular
materi
deterg
agent
use
decellular
lung
grow
alveolar
cell
cultur
first
describ
year
ago
reinvigor
test
vivo
applic
decellular
lung
mechan
ventil
undergo
vascular
perfus
provid
physiolog
studi
ex
vivo
lung
gener
two
pioneer
studi
demonstr
inocul
decellular
rat
lung
differ
mix
fetal
rat
lung
homogen
human
vascular
endotheli
cell
line
carcinoma
cell
result
recellular
decellular
scaffold
although
result
cellular
architectur
necessarili
resembl
nativ
lung
recellular
lung
abl
surgic
implant
rat
previous
undergon
unilater
pneumonectomi
shortterm
surviv
rat
degre
ga
exchang
vascular
perfus
achiev
followup
studi
demonstr
prolong
surviv
rat
implant
decellular
lung
recellular
mix
fetal
lung
human
vascular
endotheli
cell
howev
week
implant
lung
develop
extens
inflammatori
consolid
chang
although
import
proofofconcept
studi
stimul
intens
investig
also
illustr
number
practic
issu
use
decellular
human
lung
clinic
transplant
includ
sourc
lung
decellular
process
use
type
cell
inocul
use
bioreactor
cultur
system
environment
consider
implant
ethic
overal
practic
approach
regard
decellular
detergentbas
method
physic
method
freezethaw
use
howev
optim
approach
clarifi
lung
tissu
sever
differ
approach
use
lung
also
unclear
whether
age
prior
injuri
lung
affect
subsequ
decellular
recellular
recent
data
suggest
detergentbas
decellular
maintain
injuri
pattern
emphysemat
fibrot
lung
lung
obtain
older
mice
experiment
induc
fibrot
lung
injuri
appear
support
growth
prolifer
intratrach
inocul
stromal
epitheli
cell
howev
growth
epitheli
cell
significantli
diminish
decellular
lung
obtain
mice
experiment
induc
emphysemat
injuri
extracellular
matrix
protein
significantli
affect
growth
differenti
migrat
properti
lung
epitheli
cell
type
find
illustr
detail
consider
need
given
ecm
composit
decellular
lung
scaffold
storag
steril
condit
use
decellular
lung
may
significantli
affect
composit
architectur
decellular
scaffold
abil
inocul
cell
surviv
prolifer
differenti
also
unclear
whether
cadaver
lung
oppos
obtain
organ
donor
also
use
delay
necropsi
significantli
affect
composit
architectur
decellular
scaffold
abil
recellular
underli
assumpt
clinic
use
decellular
whole
organ
scaffold
includ
lung
rel
nonimmunogen
minim
detriment
host
respons
transplant
recipi
howev
ecm
protein
remain
decellular
scaffold
provok
immun
respons
may
benefici
grow
literatur
suggest
scaffoldinduc
polar
macrophag
antiinflammatori
phenotyp
subsequ
permiss
effect
implant
scaffold
regard
lung
proteom
assess
use
mass
spectrometri
andor
western
blot
demonstr
wide
rang
residu
protein
includ
intracellular
nuclear
cytoskelet
protein
remain
lung
despit
appar
effect
decellular
whether
residu
protein
provok
immun
respons
focu
intens
inquiri
overal
biolog
activ
scaffold
need
examin
care
particularli
alter
deterg
reagent
use
prepar
scaffold
includ
detail
proteom
assess
decellular
scaffold
fulli
appreci
rang
potenti
immunogen
protein
remain
scaffold
question
use
decellular
whole
lung
scaffold
clarifi
optim
approach
recellular
includ
consider
type
cell
inocul
lung
environment
condit
use
promot
growth
function
lung
tissu
grow
rang
cell
type
inocul
decellular
lung
includ
embryon
stem
cell
adult
bmderiv
msc
lung
progenitor
cell
fetal
lung
homogen
well
sever
differ
mous
human
epitheli
endotheli
cell
line
figur
combin
cell
use
order
inocul
rout
inocul
subsequ
environment
condit
optim
growth
differenti
yet
work
use
bioreactor
system
provid
close
steril
environ
vascular
perfus
positiveor
negativepressur
ventil
vermont
stem
cell
confer
one
current
approach
decellular
whole
lung
scaffold
also
provid
power
mean
studi
effect
ecm
protein
factor
growth
develop
specif
cell
type
exampl
growth
fibroblast
decellular
human
lung
obtain
patient
idiopath
pulmonari
fibrosi
promot
myofibroblast
phenotyp
mous
embryon
stem
cell
differenti
routin
tissu
cultur
dish
endoderm
cell
exhibit
phenotyp
marker
consist
atii
ati
cell
cultur
decellular
mous
lung
slice
similarli
isol
mous
atii
cell
express
immunophenotyp
marker
consist
ati
cell
phenotyp
cultur
decellular
mous
lung
scaffold
anoth
potenti
applic
decellular
lung
studi
lung
cancer
biolog
addit
genet
regulatori
program
cultur
approach
includ
use
threedimension
scaffold
mechan
forc
also
play
role
differenti
tissu
respond
gene
instruct
breath
lung
cell
subject
complex
mechan
load
includ
shear
due
air
movement
compress
due
pressur
stretch
due
expans
lung
tissu
normal
breath
review
refer
mechan
forc
utero
part
gener
fetal
breathinglik
movement
produc
rhythmic
contract
respiratori
muscl
vari
frequenc
amplitud
normal
movement
essenti
develop
fetal
lung
differenti
atii
cell
synthesi
surfact
protein
number
vitro
studi
demonstr
applic
cyclic
mechan
stretch
cultur
mix
fetal
rodent
lung
cell
increas
spc
mrna
express
compar
cell
cultur
static
condit
older
articl
review
refer
mechan
forc
also
increasingli
recogn
play
signific
role
cellular
molecular
mechan
underli
lung
injuri
recoveri
lung
injuri
stretch
mechan
influenc
fluid
shear
intens
investig
influenc
develop
tissu
cartilag
bone
vascular
structur
msc
epc
well
esc
howev
remain
rel
studi
evalu
effect
physic
forc
develop
lung
epitheli
cell
develop
threedimension
lung
structur
endogen
lung
progenitor
cell
embryon
adult
stem
cell
cultur
threedimension
scaffold
figur
challeng
develop
complex
threedimension
function
lung
tissu
ex
vivo
recapitul
normal
dynam
integr
threedimension
network
epitheli
cell
endotheli
cell
fibroblast
neuron
cell
lymphat
cell
inflammatori
cell
appropri
environ
architectur
correct
effector
molecul
mechan
forc
vital
proper
function
thorough
understand
synergist
interact
cell
physiolog
relev
condit
critic
develop
tissu
recapitul
structur
function
parent
tissu
vivo
recent
studi
demonstr
human
lung
cell
human
blood
capillari
coat
onto
porou
polydimethylsiloxan
chip
mimic
alveolar
architectur
use
studi
pathophysiolog
process
lungonachip
devic
use
evalu
nanoparticl
bacteria
enter
lung
may
also
use
highthroughput
screen
drug
field
ripe
compar
technolog
advanc
bioengin
approach
lung
regener
pro
con
move
toward
clinic
trial
msc
cell
type
epc
vigor
debat
four
confer
date
recent
meet
held
nationa
heart
lung
blood
institut
novemb
patient
safeti
remain
paramount
grow
experi
clinic
trial
diseas
particularli
mscbase
cell
therapi
continu
demonstr
shortterm
safeti
lack
signific
infusionrel
toxic
includ
sign
symptom
clinic
signific
pulmonari
emboli
two
pilot
trial
autolog
epc
administr
primari
pulmonari
hypertens
conduct
zhejiang
univers
hangzhou
china
adult
pediatr
patient
demonstr
increas
walk
capac
improv
hemodynam
variabl
includ
mean
pulmonari
arteri
pressur
pulmonari
vascular
resist
cardiac
output
week
system
administr
autolog
epc
convent
therapi
compar
patient
receiv
convent
therapi
alon
advers
effect
epc
administr
note
although
longterm
followup
pend
therapeut
trial
administr
autolog
earli
outgrowth
epc
transduc
express
eno
patient
pulmonari
hypertens
pulmonari
hypertens
cell
therapi
phacet
trial
initi
st
michael
hospit
toronto
jewish
gener
hospit
montreal
sever
epcbas
trial
list
nation
institut
health
clinicaltrialgov
websit
msc
use
clinic
trial
widen
rang
inflammatori
autoimmun
diseas
eg
graftversushost
diseas
autoimmun
diabet
crohn
diseas
acut
myocardi
infarct
one
commerci
prepar
msc
prochym
osiri
therapeut
inc
columbia
md
recent
approv
canada
use
refractori
pediatr
graftversushost
diseas
gvhd
first
licens
mscbase
cell
therapi
product
access
approv
clinic
use
one
import
find
come
clinic
trial
experi
publish
data
administr
msc
appear
safe
well
toler
even
sever
ill
patient
appear
signific
infusionrel
toxic
shortterm
advers
effect
recent
autopsi
evalu
patient
gvhd
receiv
system
msc
infus
found
evid
tumor
ectop
growth
minim
evid
sustain
presenc
day
msc
administr
although
addit
longterm
evalu
necessari
studi
provid
import
safeti
data
first
multicent
doubleblind
placebocontrol
phase
ii
trial
prochym
osiri
therapeut
inc
columbia
md
patient
moderatesever
copd
fev
fvc
fev
complet
publish
primari
goal
trial
initi
may
determin
safeti
msc
infus
patient
lung
diseas
secondari
goal
initi
estim
potenti
efficaci
msc
decreas
chronic
inflamm
associ
copd
thu
improv
pulmonari
function
qualiti
life
trial
involv
patient
six
particip
site
unit
state
trial
demonstr
safeti
older
popul
significantli
affect
patient
copd
number
comorbid
infusion
toxic
clinic
suggest
signific
pulmonari
emboli
observ
multipl
infus
either
studi
drug
vehicl
control
four
infus
per
patient
total
infus
mortal
seriou
advers
event
attribut
infus
observ
subsequ
followup
period
seriou
attribut
chang
observ
rang
safeti
assess
includ
serum
toxicolog
urinalys
ecg
echocardiogram
pulmonari
hypertens
howev
improv
efficaci
outcom
includ
pulmonari
function
evalu
qualiti
life
questionnair
physician
global
assess
observ
post
hoc
analysi
demonstr
signific
initi
decreas
circul
creactiv
protein
commonli
elev
patient
copd
subset
msctreat
versu
vehicletr
patient
elev
creactiv
protein
level
studi
onset
figur
although
trend
lost
signific
time
continu
durat
observ
period
although
trial
fail
demonstr
efficaci
provid
firm
basi
safeti
msc
use
includ
multipl
infus
patient
chronic
lung
diseas
provid
potenti
mechanist
clue
vivo
msc
effect
howev
learn
effect
mechan
msc
action
diseas
choic
becom
import
chronic
persist
lung
diseas
lowlevel
smolder
inflamm
eg
copd
diseas
current
avail
preclin
data
suggest
msc
may
worsen
diseas
process
eg
idiopath
pulmonari
fibrosi
may
best
therapeut
target
msc
intervent
acut
inflammatori
lung
system
diseas
eg
ard
sepsissept
shock
chronic
immunemedi
lung
diseas
eg
sever
asthma
may
better
target
end
clinic
trial
msc
ard
septic
shock
progress
develop
unit
state
canada
respect
demonstr
grow
effort
toward
care
conduct
close
regul
clinic
trial
cell
therapi
lung
diseas
take
place
europ
brazil
australia
unit
state
canada
small
case
seri
also
publish
detail
effect
administ
msc
patient
divers
lung
injuri
includ
lupusassoci
diffus
alveolar
hemorrhag
radiationinduc
lung
injuri
mobil
endogen
msc
patient
tuberculosi
detail
investig
requir
lung
diseas
might
amen
mscbase
cell
therapi
particular
current
avail
anim
model
lung
diseas
well
recogn
necessarili
fulli
reflect
actual
clinic
iseas
thu
develop
improv
anim
model
better
assess
potenti
effect
msc
cell
popul
continu
ripe
area
studi
addit
consider
regard
system
administr
msc
includ
use
fetal
calf
bovin
serum
versu
heterolog
speciesspecif
serum
platelet
lysat
altern
discuss
previou
confer
report
recent
nhlbi
lung
cell
therapi
meet
decemb
issu
potenti
pulmonari
emboli
system
cell
administr
cell
dose
dose
interv
rout
cell
administr
addit
continu
undergo
vigor
discuss
debat
recent
review
autopsi
patient
gvhd
receiv
system
msc
administr
evid
microemboli
found
one
patient
howev
patient
critic
ill
ard
dissemin
intravascular
coagul
time
death
could
contribut
develop
microthrombi
clinic
sign
symptom
pulmonari
emboli
observ
patient
copd
particip
phase
ii
trial
discuss
anoth
consider
clinic
use
msc
sampl
prepar
mani
approach
frozen
bag
nonhlamatch
allogen
msc
thaw
bedsid
directli
infus
although
msc
conveni
direct
way
administ
msc
recent
data
suggest
freshli
thaw
msc
may
stun
may
regain
full
immunomodulatori
properti
hour
thaw
although
yet
directli
test
head
head
anim
model
lung
diseas
optim
condit
use
msc
may
yet
establish
whether
msc
undergo
malign
transform
topic
debat
concern
examin
detail
sever
recent
articl
possibl
malign
must
care
consid
clinic
set
evalu
risk
benefit
given
patient
recent
review
autopsi
find
patient
receiv
allogen
msc
reassur
minim
presenc
msc
detect
day
administr
nonetheless
continu
intens
scrutini
longterm
followup
sensibl
caution
seem
advis
therefor
parallel
ongo
basic
scienc
investig
better
defin
rang
mechan
cell
action
commun
move
ahead
toward
clinic
trial
follow
three
question
must
address
safe
shortterm
safeti
concern
method
address
far
allevi
treatment
potenti
caus
harm
case
point
idiopath
pulmonari
fibrosi
use
admittedli
imperfect
preclin
rodent
model
lung
fibrosi
avail
data
suggest
msc
administr
set
establish
lung
fibrosi
benefici
effect
contribut
fibrot
process
propos
cell
therapi
approach
potenti
efficaci
critic
import
understand
mechan
msc
cellbas
action
specif
lung
diseas
pathogenes
robust
preclin
literatur
support
use
mscbase
therapeut
approach
acut
lung
critic
ill
inflammatori
injuri
ard
sepsi
well
bronchopulmonari
dysplasia
chronic
immun
mediat
condit
bronchiol
obliteran
asthma
remain
sens
equipois
preclin
lung
diseas
model
necessarili
fulli
mimic
human
diseas
pathogenes
predict
clinic
behavior
ongo
plan
clinic
trial
varieti
lung
diseas
critic
ill
sepsi
north
america
part
world
must
proceed
care
cautious
commun
must
care
overestim
potenti
promis
cellbas
therapi
grow
number
websit
venu
offer
unsubstanti
claim
cell
therapi
efficaci
rang
lung
diseas
signific
harm
even
death
may
result
patient
undergo
treatment
fda
recent
begun
work
government
agenc
attempt
regul
case
close
websit
make
unsubstanti
claim
promin
nonprofit
respiratori
diseas
foundat
includ
american
thorac
societi
american
lung
associ
pulmonari
hypertens
associ
join
promin
stem
cell
societi
notabl
intern
societi
stem
cell
research
issu
strong
statement
stem
cell
medic
tourism
respect
websit
stem
cell
work
group
american
thorac
societi
coordin
effort
lead
respiratori
diseas
foundat
issu
compar
statement
take
compar
posit
n
author
disclosur
avail
text
articl
wwwatsjournalsorg
